A detailed history of Pekin Hardy Strauss, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Pekin Hardy Strauss, Inc. holds 1,226 shares of LLY stock, worth $1.11 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
1,226
Previous 1,290 4.96%
Holding current value
$1.11 Million
Previous $751,000 26.9%
% of portfolio
0.14%
Previous 0.11%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

SELL
$592.2 - $792.28 $37,900 - $50,705
-64 Reduced 4.96%
1,226 $953,000
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $6,827 - $8,048
13 Added 1.02%
1,290 $751,000
Q3 2023

Nov 07, 2023

BUY
$434.7 - $599.3 $86,940 - $119,859
200 Added 18.57%
1,277 $685,000
Q2 2023

Aug 08, 2023

BUY
$350.74 - $468.98 $89,087 - $119,120
254 Added 30.86%
1,077 $505,000
Q1 2023

May 08, 2023

SELL
$310.63 - $364.82 $93,189 - $109,446
-300 Reduced 26.71%
823 $282,000
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $3,215 - $3,746
10 Added 0.9%
1,123 $410,000
Q3 2022

Nov 09, 2022

BUY
$296.48 - $337.87 $12,748 - $14,528
43 Added 4.02%
1,113 $360,000
Q2 2022

Aug 05, 2022

BUY
$278.73 - $327.27 $18,953 - $22,254
68 Added 6.79%
1,070 $347,000
Q4 2021

Feb 08, 2022

SELL
$224.85 - $279.04 $22,485 - $27,904
-100 Reduced 9.07%
1,002 $277,000
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $22,160 - $27,270
100 Added 9.98%
1,102 $255,000
Q2 2021

Aug 12, 2021

BUY
$180.55 - $233.54 $180,911 - $234,007
1,002 New
1,002 $230,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Pekin Hardy Strauss, Inc. Portfolio

Follow Pekin Hardy Strauss, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pekin Hardy Strauss, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pekin Hardy Strauss, Inc. with notifications on news.